2D-BioPAD 7th project meeting in Kuopio, Finland
The 7th project meeting of the 2D-BioPAD project took place on November 10-11, 2026 in Kuopio, Finland, bringing...
Read more
2D-BioPAD is pioneering a graphene-based Point-of-Care (PoC) In-Vitro Diagnostics (IVD) system for early Alzheimer’s Disease (AD) detection. This non-invasive solution, using 2D materials, can identify and quantify up to 5 AD biomarkers in real-time. Clinical pilot studies in Finland, Greece, and Germany aim to demonstrate its impact, with a focus on safety, ethics, and seamless integration into primary healthcare settings.
The 7th project meeting of the 2D-BioPAD project took place on November 10-11, 2026 in Kuopio, Finland, bringing...
Read more
For the third consecutive year, 2D-BioPAD and MUNASET joined forces during Graphene Week 2026 to organise their joint...
Read more
For the third consecutive year, the 2D-BioPAD and MUNASET projects are joining forces at Graphene Week 2026 to...
Read more
The 2D-BioPAD project was represented at Health Insight 2026, held in Kuopio, Finland, on August 19-20, 2026, by...
Read more